When launching a new drug, especially one that addresses a high unmet need, the barriers to access are numerous. Cost, formulary placement, and prior authorization and step therapy restrictions can all prevent patients from picking up their medication at the prescription counter.
“It is very important that if a doctor makes a decision to place a patient on a therapy, that they have confidence that the ‘script-to-fill’ process is right,” said the vice president of market access at a small pharma company that launched its first commercial product in March of 2020.
To overcome these types of hurdles at launch, the company tracked shifts in coverage and payer policies for its drug and competitors’ drugs. Read the full case study to learn how.
